Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-26

Clinical Trial Update: Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism [Phase 4]

View source ↗

Summary

A Phase 4 trial from Beijing Children's Hospital is evaluating a combination of human menopausal gonadotropin and human chorionic gonadotropin to treat congenit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human chorionic gonadotropin (human chorionic gonadotropin)
  • Human menopausal gonadotropin (human menopausal gonadotropin)

Snippet

Sponsor: Beijing Children's Hospital | Conditions: Kallmann Syndrome, Hypogonadotropic Hypogonadism | Phase 4 | Status: UNKNOWN